MERCK KGAA I (MRK.DE)
Supplies lab equipment and chemicals for research, plus makes cancer and rare disease medicines.
144.25+0.02%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+34.6%
The outlook
Merck KGaA is trading near its 52-week high with analyst consensus leaning Buy across strong coverage. The stock sits above both its 50- and 200-day moving averages, reflecting solid near-term momentum. Analyst price targets average about 1% above current levels, and the trailing P/E of 24.7 reflects a valuation premium relative to broader markets.
What’s behind the score
Analyst consensusBuy — 2.2 avg of 14 analysts
Price trendAbove its 50- & 200-day averages
52-week range91% of the way from its 52-week low to high
Price targetAvg target +1% vs current price
Analyst price target
~12-month · 14 analysts146.29average target+1.4% vs now
Now 144.25
Low 121.00High 179.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
—
52-wk high
148.65
52-wk low
100.70
50-day avg
136.35
200-day avg
122.21
Trailing P/E
24.7